Department of Physical Activity and Rehabilitation Sciences, University of Liege, 4000 Liege, Belgium.
Department of Physical Medicine and Rehabilitation, University Hospital Centre, 4000 Liege, Belgium.
Sensors (Basel). 2024 May 22;24(11):3300. doi: 10.3390/s24113300.
We assessed the test-retest reliability and discriminative ability of a somatosensory temporal discrimination (SSTD) assessment tool for fibromyalgia syndrome (FMS) and determined if pain-related variables were associated with SSTD performance. Twenty-five women with FMS and twenty-five asymptomatic women were assessed during two sessions 7 to 10 days apart. The proportion of correct responses (range 0-100) was calculated. Sociodemographic information was collected for both groups. The participants with FMS also completed the widespread pain index and the Brief Pain Inventory. Test-retest reliability was verified by calculating intraclass correlation coefficients. Discriminative ability was verified by a between-group comparison of scores using a -test. Associations between SSTD score and pain variables were tested using Pearson or Spearman correlation coefficients. The test-retest reliability of the SSTD score was excellent (ICC > 0.9, CI: 0.79-0.96) for the asymptomatic group and good for the FMS group (ICC: 0.81, 95% CI: 0.62-0.91). The median (Q1-Q3) test session SSTD score differed significantly between the FMS 84.1 (71-88) and the asymptomatic 91.6 (83.4-96.1) groups ( < 0.001). Only pain duration was associated with the SSTD score. In conclusion, the new SSTD test seems reliable for people with FMS and is discriminative. Further studies should examine its sensitivity to change and correlations with other SSTD tests.
我们评估了一种用于纤维肌痛综合征(FMS)的体感时间辨别(SSTD)评估工具的重测信度和区分能力,并确定与 SSTD 表现相关的疼痛相关变量。25 名 FMS 女性和 25 名无症状女性在相隔 7 至 10 天的两次检查中接受评估。计算正确反应的比例(范围 0-100)。收集了两组的社会人口统计学信息。FMS 患者还完成了广泛性疼痛指数和简明疼痛量表。通过计算组内相关系数来验证重测信度。通过 t 检验对两组之间的分数进行比较来验证区分能力。使用 Pearson 或 Spearman 相关系数测试 SSTD 分数与疼痛变量之间的相关性。SSTD 分数的重测信度对于无症状组非常好(ICC>0.9,CI:0.79-0.96),对于 FMS 组则为良好(ICC:0.81,95%CI:0.62-0.91)。FMS 组的中位数(Q1-Q3)测试会话 SSTD 评分 84.1(71-88)与无症状组的 91.6(83.4-96.1)组有显著差异(<0.001)。只有疼痛持续时间与 SSTD 评分相关。总之,新的 SSTD 测试似乎对 FMS 患者可靠且具有区分能力。进一步的研究应该检查其对变化的敏感性以及与其他 SSTD 测试的相关性。